Volume 389, Issue 10068, Pages 538-546 (February 2017) Use of MRI in the diagnosis of fetal brain abnormalities in utero (MERIDIAN): a multicentre, prospective cohort study  Prof Paul D Griffiths, FRCR, Michael Bradburn, MSc, Prof Michael J Campbell, PhD, Prof Cindy L Cooper, PhD, Ruth Graham, PhD, Deborah Jarvis, BSc, Prof Mark D Kilby, DSc, Gerald Mason, MD, Cara Mooney, MSc, Prof Stephen C Robson, MD, Prof Allan Wailoo  The Lancet  Volume 389, Issue 10068, Pages 538-546 (February 2017) DOI: 10.1016/S0140-6736(16)31723-8 Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license Terms and Conditions

Figure 1 Trial profile *One participant carried two fetuses: one fetus was a complete dataset and the other fetus incomplete. Therefore the participant is counted in both the incomplete and complete data boxes. †176 had iuMR <2 weeks from referral.‡Fetal medicine management decision made. §Gestational age at time of MRI. The Lancet 2017 389, 538-546DOI: (10.1016/S0140-6736(16)31723-8) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license Terms and Conditions

Figure 2 The proportion of diagnoses made with high and low confidence on antenatal ultrasound and iuMRI in the 570 patients with complete outcome data and who had iuMRI within 2 weeks of the ultrasound Diagnoses were compared with the outcome reference diagnoses. iuMRI=in-utero MRI. The Lancet 2017 389, 538-546DOI: (10.1016/S0140-6736(16)31723-8) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license Terms and Conditions